Status:

COMPLETED

Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease

Lead Sponsor:

Boston University Charles River Campus

Collaborating Sponsors:

University of New England

National Institute on Aging (NIA)

Conditions:

Parkinson Disease

Eligibility:

All Genders

40-85 years

Phase:

NA

Brief Summary

Regular, habitual exercise is a critical component of the long-term management of Parkinson disease (PD). However, PD-specific motor (e.g. slow and diminished movements, variable step timing) and non-...

Detailed Description

Parkinson disease (PD) is the fastest growing source of disability among neurological disorders. Diminished physical activity is highly prevalent in PD and often lead to the onset of disability. Regul...

Eligibility Criteria

Inclusion

  • Diagnosis of idiopathic, typical Parkinson disease (based on the UK PD Society Brain Bank Criteria7) by a physician
  • Modified Hoehn and Yahr stages 1-3 per physical exam by a licensed physical therapist
  • 40 - 85 years of age
  • Community-dwelling
  • Able to walk independently without physical assistance or an assistive device for at least 10 minutes.
  • Have stable PD medications for at least two weeks prior to enrollment.
  • Willing and able to provide informed consent.
  • Provide HIPAA Authorization to allow communication with the primary healthcare provider for communication (as needed) during the study period.

Exclusion

  • \< 40 years of age
  • Diagnosis of atypical Parkinsonism
  • Modified Hoehn and Yahr stages 4-5
  • Moderately or significantly disturbing freezing episodes during daily walking based on the New Freezing of Gait Questionnaire
  • History of \>1 fall over the past 3 months
  • Cognitive impairment (i.e., Mini-Mental State Exam Score (MMSE) \< 24)
  • Unable to walk independently (i.e. without physical assistance or assistive device) at a comfortable speed of 0.4m/s or greater (i.e., 10-meter Walk Test (10mWT))
  • Unable to independently use the music-based digital therapeutic during training
  • Significant hearing impairment
  • Currently participating in physical therapy
  • Currently performing regular walking exercise \> 3x/week for 30 minutes per session.
  • Cardiac conditions that may limit safe participation in exercise
  • Orthopedic conditions that may limit safe participation in exercise
  • Any other medical conditions that would preclude successful participation as determined by a physical therapist

Key Trial Info

Start Date :

August 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2023

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT05421624

Start Date

August 1 2022

End Date

November 1 2023

Last Update

May 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center for Neurorehabilitation at Boston University

Boston, Massachusetts, United States, 02215